Novo Nordisk to sell weight-loss drug for $499 to eligible customers

Novo Nordisk to sell weight-loss drug for $499 to eligible customers

Novo Nordisk previously announced in March decision to cut Wegovy pricing as competition intensifies with Eli Lilly